BioVoice News eMag January-February 2024 | Page 15

Our strategic investments in
2024 will generate 3000 new jobs
developing and providing access to high-quality vascular intervention devices , orthopaedic implants , in-vitro diagnostics , surgical devices , ENT products and Robotics across 135 countries . It has partnered with renowned institutions and experts across the globe to foster innovation and gain access to global distribution networks . By harnessing advanced technologies & collaborations the company has delivered several stateof-the-art medical devices such as CUVIS Joint – fully robotic surgery system , BioResorbable stents such as MeRes100 and next gen transcatheter aortic valves replacement system such as Myval that meets global standards .
Meril was also honoured for its # TreatmentZarooriHai public awareness campaign early this year . Its goal is to raise awareness among Indian residents about the importance of early detection and treatment of heart diseases like coronary artery disease and aortic stenosis as well as osteoarthritis and knee replacement surgeries .
Meril recently received the World Intellectual Property Organisation ( WIPO ) IP Enterprise Award and the Government of India ' s Ministry of Chemicals & Fertilisers Department of Pharmaceuticals ' India Medical Devices Innovation of the Year award . Meril also signed an agreement with Japan ’ s leading cardiovascular medtech company , Japan Lifeline .

Our strategic investments in

2024 will generate 3000 new jobs

As we step into 2024 and beyond , the landscape for medical device technologies originating in India holds tremendous promise , fueled by the nation ' s robust innovation engine . Meril , standing as a key player , is strategically positioned to cater to both domestic and international demands , steering this progress through sustained investments in its globally acclaimed manufacturing facility . With a focus on producing high-quality vascular intervention devices and orthopedic implants , Meril ' s commitment extends to the ongoing development and manufacturing of advanced robotic-assisted surgical solutions , as well as the expansion of point-of-care diagnostics .
Meril ’ s strategic investments in 2024 is not only projected to generate approximately 3000 new jobs , thus fostering significant economic growth in the region , but it also fortifies the groundwork for India ' s leadership in cutting-edge sectors . Looking ahead , India is poised to pioneer the design and production of next-generation biomimicking implants . Additionally , the seamless integration of AI and machine learning-based tools positions India as a global hub for innovative medical technologies . This synchronized approach propels both economic development and technological innovation , solidifying India ' s role on the global stage .
BIOVOICENEWS . COM 15